Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2005
03/10/2005WO2005021535A2 A method of removing the triphenylmethane protecting group
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005WO2005021512A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021510A2 Benzimidazole c-2 heterocycles as kinase inhibitors
03/10/2005WO2005021505A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021495A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/10/2005WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
03/10/2005WO2005020921A2 C-kit modulators and methods of use
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004096128A3 Hiv integrase inhibitors
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005US20050054713 3-Substituted oxindole beta3 agonists
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells
03/10/2005US20050054709 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
03/10/2005US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
03/10/2005US20050054679 For therapy of psychiatric and neurological disorders
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054655 Benzimidazole C-2 heterocycles as kinase inhibitors
03/10/2005US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054630 Fused bicyclic carboxamide derivatives and methods of their use
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005CA2537349A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005CA2537123A1 New compounds
03/10/2005CA2536781A1 A method of removing the triphenylmethane protecting group
03/10/2005CA2536151A1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
03/10/2005CA2535896A1 N-substituted benzimidazolyl c-kit inhibitors
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005CN1592749A Intermediates for preparing glycogen phosphorylase inhibitors
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1590465A Cyanine compound, optical recording material, and optical recording medium
03/09/2005CN1590378A Quinoxaline derivative and its preparation method and use
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864268 Antidiabetic agents
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864255 Substituted triazinyl amide derivatives and methods of use
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6864219 Substituted aryl ketones
03/03/2005WO2005019216A1 Aminobenzimidazole derivatives
03/03/2005WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same
03/03/2005WO2005019208A1 Substituted 3-pyrrolidin-indole derivatives
03/03/2005WO2005019207A1 Fungicidal pyrimidine derivatives
03/03/2005WO2005019182A1 Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
03/03/2005WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019168A2 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
03/03/2005WO2005019167A2 Melanin concentrating hormone receptor antagonist
03/03/2005WO2005018644A1 Capped pyrazinoylguanidine sodium channel blockers
03/03/2005WO2005018547A2 Mitotic kinesin inhibitors
03/03/2005WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
03/03/2005WO2005005378A3 Indolinone hydrazides as c-met inhibitors
03/03/2005WO2004083173A3 Ketopiperazine derivatives as bradykinin antagonists
03/03/2005WO2004076410A3 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
03/03/2005WO2004039894A3 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005US20050049413 Quinoline derivatives
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049290 Benzimidazole derivatives and their use as gnrh antagonists
03/03/2005US20050049288 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS
03/03/2005US20050049277 Histamine H3 receptor antagonists; such as 2-(4-(n-ethyl)anilinoethoxyphenyl)imidazo[1,2-a]pyridine
03/03/2005US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders
03/03/2005US20050049247 Pyrimidines useful as modulators of voltage-gated ion channels
03/03/2005US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis
03/03/2005US20050049237 Pyrazole-amides and -sulfonamides
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2536095A1 Aminobenzimidazole derivatives
03/03/2005CA2533889A1 Mitotic kinesin inhibitors
03/03/2005CA2533112A1 Melanin concentrating hormone receptor antagonist
03/03/2005CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509574A1 Yellow anionic disazo dyes
03/02/2005EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
03/02/2005EP1509518A1 Calcium receptor modulating agents
03/02/2005EP1509517A2 Novel synthesis of irbesartan
03/02/2005EP1509507A2 Mitotic kinesin inhibitors
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 626